[Management and prognosis of metastatic ovarian carcinoma from nongenital tract].
To study the management and prognosis of nongenital metastatic ovarian carcinoma. Thirty-four patients with nongenital metastatic ovarian carcinoma who were admitted in to Zhongnan Hospital of Wuhan University between 1998 and 2004 were analyzed retrospectively. The median survival time of group A (optimal cytoreductive surgery), group B (optimal cytoreductive surgery + chemotherapy), group C (sub-optimal cytoreductive surgery) and group D (sub-optimal cytoreductive surgery + chemotherapy) was 5.0, 10.0, 4.0 and 6.5 months, respectively. The difference was significant between groups A and B, B and C, as well as between group C and D (P < 0.05). Most of nongenital metastatic ovarian carcinomas come from tumors of stomach and intestine. Optimal cytoreductive surgery and chemotherapy play an important role in the management and prognosis of nongenital metastatic ovarian carcinoma.